Lobbying

Center for Addiction Science, Policy, and Research's latest lobbying report covers Q3 2026, at under $5,000. The four quarters Q4 2025–Q3 2026 total $40K. Its first report covers Q3 2024; the issues it reports most are Alcohol & Drug Abuse and Health Issues.

Center for Addiction Science, Policy, and Research

Latest quarter
$0
Q3 2026 · 1 reports
Last 12 months
$40K
Last 4 quarters
vs last quarter
−100.0%
Q3 2026 against the quarter before
First report
Q3 2024
The first quarter a report named it

Lobbying by quarter

Center for Addiction Science, Policy, and Research lobbying by quarter
Center for Addiction Science, Policy, and Research lobbying by quarter
QuarterAmountReports
Q3 2024$01
Q4 2024$10K1
Q1 2025$30K1
Q2 2025$20K1
Q3 2025$30K1
Q4 2025$10K1
Q1 2026$20K1
Q2 2026$10K1
Q3 2026$01

By issue

  • Alcohol and drug abuse$31K · 9 reports
  • Health issues$31K · 9 reports
  • Budget and appropriations$28.5K · 7 reports
  • Veterans$25K · 6 reports
  • Commodities$6,000 · 3 reports
  • Gaming and casinos$6,000 · 3 reports
  • Defense$2,500 · 1 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

  • HOUSE OF REPRESENTATIVES9 reports
  • SENATE9 reports
  • Food & Drug Administration (FDA)8 reports
  • Health & Human Services, Dept of (HHS)7 reports
  • Veterans Affairs, Dept of (VA)6 reports
  • Centers For Medicare and Medicaid Services (CMS)3 reports
  • Substance Abuse & Mental Health Services Administration (SAMHSA)2 reports
  • Defense, Dept of (DOD)1 reports

Firms it paid

Firm
Tenagrity Solutions$130K9 quarters

Former officials lobbying for it

Former position
JENNY CAROLINE DEBERRYSenior Legislative Assistant/ Legislative Assistant, Congressman John J. Duncan, Jr.; Senior Campaign Finance Analyst/ Campaign Finance Analyst, Federal Election CommissionQ3 2026

Lobbying reports

Filed by
07/24for Q3Tenagrity SolutionsUnder $5,000
07/20for Q2Tenagrity Solutions$10K
04/20for Q1Tenagrity Solutions$20K
01/20for Q4 2025Tenagrity Solutions$10K
25/10/20for Q3 2025Tenagrity Solutions$30K
25/07/21for Q2 2025Tenagrity Solutions$20K
25/04/21for Q1 2025Tenagrity Solutions$30K
25/01/14for Q4 2024Tenagrity Solutions$10K
24/10/18for Q3 2024Tenagrity SolutionsUnder $5,000
24/07/19for Q3 2024Tenagrity SolutionsUnder $5,000